Search
Now showing items 1-2 of 2
Reintroduction of elective cardiac interventions in the era of COVID-19: the Barts experience.
(2021-04)
BACKGROUND: The response to COVID-19 has required cancellation of all but the most urgent procedures; there is therefore a need for the reintroduction of a safe elective pathway. METHODS: This was a study of a pilot pathway ...
Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention.
(2018-10)
OBJECTIVES: Prasugrel and ticagrelor both reduce ischaemic endpoints in high-risk acute coronary syndromes, compared with clopidogrel. However, comparative outcomes of these two newer drugs in the context of primary ...